search

Active clinical trials for "Pulmonary Embolism"

Results 191-200 of 604

PREvention of VENous ThromboEmbolism Following Radical Prostatectomy

Prostate CancerVenous Thromboembolism3 more

The PREVENTER Trial aims to compare the use of perioperative pharmacologic prophylaxis (subcutaneous heparin) with intermittent pneumatic compression devices (IPCs) to the use of IPCs alone for the prevention of venous thromboembolism (VTE) after radical prostatectomy (RP).

Terminated8 enrollment criteria

Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease

Venous ThromboembolismVenous Thrombosis1 more

REMMITE, a retrospective and prospective registry with one-year follow-up, will provide valuable insights into the clinical diagnosis, management, treatment trends as well as related outcomes of three cohorts: DVT, DVT-PE, PE patients throughout many regions of Mexico and through different health care systems.

Not yet recruiting5 enrollment criteria

Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation

Permanent Atrial FibrillationVenous Thrombosis2 more

The VICTORIA Study (Vascular CalcIfiCation and sTiffness induced by ORal antIcoAgulation) is a comparative, parallel, prospective, controlled and randomized study of the structural and functional impact of rivaroxaban versus anti-vitamin K drugs on the arterial vasculature.

Completed25 enrollment criteria

Standard vs. Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary Embolism

Pulmonary Embolism

The study will compare standard catheter directed thrombolysis to ultrasound accelerated thrombolysis for the treatment of acute submassive pulmonary embolism (PE). The study population will include patients eligible for catheter directed thrombolysis (CDT) for submassive PE. Subjects will be randomized to, either, standard catheter-directed thrombolysis or ultrasound-accelerated thrombolysis (USAT).

Completed13 enrollment criteria

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy...

Pulmonary EmbolismAcute Pulmonary Embolism3 more

The purpose of this study is to determine if the EKOS EkoSonic® Endovascular Device when used in conjunction with recombinant tissue plasminogen activator (t-PA) as a treatment for acute PE will decrease the ratio of right ventricle (RV) to left ventricle (LV) diameter within 48 =/- 6 hours in participants with massive or submassive PE.

Completed23 enrollment criteria

12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China

Pulmonary EmbolismThromboembolism

Comparative trials of urokinase (UK) for 12 hours(UK-12h)or 24 hours (UK-24h) have produced similar results in acute pulmonary thromboembolism (PTE) thrombolysis. It is unclear whether the infusion time can be reduced further. The aim of this study was to investigate the efficacy and safety of weight adjusted dosage of UK-2h (20 000 IU/Kg) regime with the Uk-12h regime in selected patients with PTE in Chinese population.

Completed22 enrollment criteria

Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter System 3 ("RETRIEVE 3")

Pulmonary Embolism

The purpose of this study is to determine if the Crux Vena Cava Filter System is safe and effective in preventing pulmonary embolism.

Completed37 enrollment criteria

Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter 4

Pulmonary Embolism

The purpose of this study is to determine if the Crux Vena Cava Filter System is safe and effective in preventing pulmonary embolism.

Completed37 enrollment criteria

PEITHO Pulmonary Embolism Thrombolysis Study

Pulmonary Embolism

Heparin is the reference therapy for most patients with pulmonary embolism. Some patients with sub-massive pulmonary embolism defined by normal blood pressure and dysfunction of the right ventricle have a higher mortality risk. It has been suggested that thrombolytic treatment, a drug that dissolves blood clots more rapidly, may reduce the mortality in those patients. The studies reported to date were unable to confirm or refute this hypothesis because the number of patients included in those studies is too low. The aim of the study is to compare thrombolytic treatment with heparin (which is the reference therapy for pulmonary embolism) in a large group of patients with sub-massive pulmonary embolism.

Completed14 enrollment criteria

Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism

Pulmonary Embolism

To investigate PK and coagulating and fibrinolytic parameter profiles (PD) at the approved dose (13,750 - 27,500 IU/kg) in patients with acute pulmonary embolism accompanying hemodynamic instability.

Completed25 enrollment criteria
1...192021...61

Need Help? Contact our team!


We'll reach out to this number within 24 hrs